MP

Meghan Pagliarini

Executive Liaison to the President and CEO

Vigil Neuroscience

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Vigil Neuroscience
Industry
research
Employees
86.0
Seniority
C suite
Annual Revenue
1000000.0

Technologies

NetSuite Mimecast Outlook Microsoft Office 365 Mobile Friendly Typekit Google Font API Vimeo Bootstrap Framework Remote AI

Keywords

neuroscience & microglia biotechnology: biological products (no diagnostic substances) health care biotechnology research microglia neurodegenerative diseases trem2 precision medicine therapeutic candidates patient advocacy clinical trials genetic testing drug development small molecules trem2 activation brain homeostasis immune cells rare diseases adult-onset leukoencephalopathy alsp community engagement clinical research therapeutic programs inflammatory cns damage precision-based therapies collaboration disease management biomarkers neural degeneration patient experience neurology research risk factors for alzheimer's phagocytosis microglial function therapeutic solutions healthcare collaboration clinical development patient-centered care scientific advisory board community support research publications iv therapy oral medications disease progression genetic mutations neuroimaging patient-community interaction longitudinal studies innovative treatments biotechnology microglial dysfunction therapeutic innovation trem2 agonist iluzanebart vg-3927 alzheimer's disease patient engagement common diseases neuroscience drug development clinical-stage monoclonal antibody small molecule therapy patient-centric approach neuroinflammation genetic microglia dysregulation cns disorders research & development transformative therapeutics health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans